Which two drugs should not be given with ephedrine, and why?

Which two drugs should not be given with ephedrine, and why?

• A. MAO inhibitors and cocaine
• B. Beta blockers and nitrates
• C. ACE inhibitors and ARBs
• D. Diuretics and benzodiazepines

Answer: (A)

The main idea is that ephedrine can provoke a strong sympathetic response by both directly stimulating receptors and indirectly increasing norepinephrine release. When paired with drugs that dramatically raise catecholamine activity or block its breakdown, this response can become dangerous. With monoamine oxidase inhibitors, the breakdown of norepinephrine is inhibited. Ephedrine’s indirect mechanism increases norepinephrine release, so combining the two leads to a much higher level of adrenergic stimulation. That can trigger a hypertensive crisis, tachyarrhythmias, and potential organ injury due to excessive vasoconstriction and cardiac workload. With cocaine, the drug blocks reuptake of norepinephrine (and other monoamines), leaving more not only at the synapse but also enhancing sympathetic tone. Adding ephedrine further increases norepinephrine release and receptor stimulation, again risking severe hypertension, arrhythmias, myocardial ischemia, or stroke from excessive vasoconstriction and cardiac strain. Other options don’t carry this same direct, high-risk interaction profile with ephedrine, so the combination of these two classes remains the dangerous pairing to avoid.

The main idea is that ephedrine can provoke a strong sympathetic response by both directly stimulating receptors and indirectly increasing norepinephrine release. When paired with drugs that dramatically raise catecholamine activity or block its breakdown, this response can become dangerous.

With monoamine oxidase inhibitors, the breakdown of norepinephrine is inhibited. Ephedrine’s indirect mechanism increases norepinephrine release, so combining the two leads to a much higher level of adrenergic stimulation. That can trigger a hypertensive crisis, tachyarrhythmias, and potential organ injury due to excessive vasoconstriction and cardiac workload.

With cocaine, the drug blocks reuptake of norepinephrine (and other monoamines), leaving more not only at the synapse but also enhancing sympathetic tone. Adding ephedrine further increases norepinephrine release and receptor stimulation, again risking severe hypertension, arrhythmias, myocardial ischemia, or stroke from excessive vasoconstriction and cardiac strain.

Other options don’t carry this same direct, high-risk interaction profile with ephedrine, so the combination of these two classes remains the dangerous pairing to avoid.